Market overview

Tetrabutylammonium bromide (TBAB, CAS 1643-19-2) is the most widely used quaternary ammonium phase-transfer catalyst, enabling alkylation, esterification and nucleophilic substitution between aqueous and organic phases. It is also used as an electrolyte additive, in ionic liquids and deep eutectic solvents, and in semi-clathrate hydrate systems for cold-energy storage. Pharmaceutical and agrochemical intermediate production in India and China dominates consumption.

The question this report answers
Where is tetrabutylammonium bromide demand growing, from phase-transfer catalysis to battery electrolytes?

Market Krystal preliminary estimate (2025)
DataHorizzon values TBAB at USD 187.4 mn (2025). We use USD 150-200 mn. Confidence grade B: one published estimate, checked against volumes or prices.

Market dynamics
– Demand: phase-transfer catalysis (38%), pharmaceutical synthesis, electrolyte additives (fastest growing)
– Supply: China and India dominate quaternary ammonium production
– Price and margin: tributylamine and butyl bromide drive cost
– Regulation: limited; standard handling

Key figures at a glance (third-party, cited)
– TBAB market: USD 187.4 mn (2025) to USD 312.8 mn by 2033 at 6.8% CAGR (DataHorizzon Research)
– Phase-transfer catalysis holds the largest application share at 38%; electrolyte additives are the fastest growing at 8.9% CAGR (DataHorizzon Research)
– Asia-Pacific accounts for USD 76.8 mn (41%) of 2025 demand (DataHorizzon Research)

Recent developments among key stakeholders
– H1 2026: China’s electrolyte output reached 1.416 Mt (+56% y/y), the outlet for TBAB’s fastest-growing use as an electrolyte additive (SMM)
– No major company-specific announcements for this CAS were identified in public sources for 2025-2026; the report tracks producer activity through customs data, regulatory filings and supplier interviews

What this means for the market
Battery-related demand is a small but fast-rising addition to TBAB’s phase-transfer base. The report quantifies its share.

How published estimates compare
DataHorizzon’s company list is dominated by distributors and diversified majors rather than the Indian and Chinese quaternary-ammonium producers that supply most volume. Market Krystal identifies actual manufacturing sites and capacities and separates manufacturing revenue from resale.

Strategic scenarios to 2047
– Base: crop-protection and generic-drug volumes grow with food demand and patent expiries; intermediates follow their downstream actives, with China and India as main producers.
– Constrained supply: Chinese environmental inspections, export restrictions or Western ‘China-plus-one’ rules tighten intermediate supply; qualified Indian and Western sources gain share and pricing.
– Technology transition: new actives, biologicals and regulatory bans retire older molecules, so demand for a given intermediate can fall sharply when its downstream product loses registration or patent protection.
The swing factor for Tetrabutylammonium bromide is electrolyte additive adoption beyond phase-transfer catalysis. Signposts: EU and US re-registration decisions, patent expiries, Chinese production curbs, India PLI investments.

What this report delivers
Annual volume (tonnes) and value (USD) for 2026-2035, segmented by application: phase-transfer catalysis, pharmaceutical synthesis, electrolytes, ionic liquids, hydrate storage; grade: technical, pharma, electrochemical; region: India, China, Europe, North America. Each segment is backed by a producer capacity table, price benchmarks for 2020-2025 by grade and region, trade-flow analysis and a supplier risk map. Companies assessed include Sachem, Tatva Chintan, Indian and Chinese quaternary-ammonium producers, Merck KGaA, Tokyo Chemical Industry. The 2036-2047 outlook uses three explicit scenarios (base, constrained supply and technology transition) rather than a single extrapolated curve.

Who uses this report
Agrochemical and pharmaceutical process teams, CDMOs, intermediate producers in India and China, and sourcing managers.

Why our approach is evidence-based
Most CAS-level market listings publish a single number with no audit trail, and we regularly find figures that contradict their own growth rates or exceed the size of the market they sit inside. Market Krystal works the other way round. We start from physical evidence: plant capacities, production and trade data, company disclosures, regulatory texts and price records. We build volume and price separately and only then compute value. Every third-party figure is cited, every Market Krystal estimate is labelled with its method and a confidence grade, and conflicts between sources are shown rather than hidden. Confidence grades: A = two or more independent sources agree, or government or company data; B = one published estimate checked against volumes or prices; C = no reliable published figure, so the range is built from stated assumptions and narrowed in the full report.

Methodology and delivery
Prepared by the Market Krystal Chemicals Research Team. Each report is built around the buyer’s question: after purchase, a short scope confirmation fixes the priority regions, companies and applications, and the report is delivered within 5-7 business days with the Excel model behind every estimate, so buyers can audit and change the assumptions.

The purchased delivery includes the PDF report, Excel datasets and customization around the buyer’s priority region, company set, application or commercial question.

What this research answers

The study connects production routes, named suppliers, applications, regional demand, trade, pricing drivers and commercial opportunities for this CAS number. Detailed estimates and company analysis remain inside the purchased report.